ELV Stock Analysis: Buy, Sell, or Hold?
ELV - Elevance Health, Inc.
$417.89
1.70 (0.41%)
▲
5d:
+7.89%
30d:
+7.42%
90d:
+40.0%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 16, 2026
12d
Smart Money Distribution
None View Scanner →
Strength: 6.8/10
Get Alerted When ELV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ELV shows positive signals but monitor for confirmation. Market pricing in 5.4% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ELV shows positive signals but monitor for confirmation. Market pricing in 5.4% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$485.14
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$301.24
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELV is currently trading at $417.89, which is considered extended relative to its 30-day fair value range of $387.62 to $410.03. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.3) compared to its historical average (12.2). At these levels, the market is pricing in 5.4% annual earnings growth.
Technical Outlook: Technically, ELV is in a uptrend. The price is approaching resistance at $426.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELV is in a uptrend. The price is approaching resistance at $426.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$387.62 -
$410.03
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($418.67)
- BULLISH: Expecting earnings turnaround to 5.4% growth with 2.6% revenue growth
Trading Range Analysis
30-Day Trading Range
$387.62 -
$410.03
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$386.76
Resistance Level
$426.66
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.29
Wall Street Target
$418.67
(+0.2%)
Revenue Growth (YoY)
2.6%
Earnings Growth (YoY)
-16.8%
Profit Margin
2.6%
Valuation Premium vs History
+5.4% premium
PE vs Historical
14.3 vs 12.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.4%
(market-implied from PE analysis)
1-Year Target
$440.46
(+5%)
2-Year Target
$464.24
(+11%)
3-Year Target
$489.31
(+17%)
3-Yr Target (if PE normalizes)
(PE: 14→12)
PE COMPRESSION
$417.80
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.7%)
$818.49
(+96%)
Base:
(SPY PE: 14.3, Growth: 8.7%)
$536.94
(+29%)
Bear:
(PE: 12.1, Growth: 8.7%)
$456.40
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 17.64 | Current EPS (TTM): $23.60
Bull Case
$567.36
(+36%)
Analyst growth 23.9%, PE expands to 19.4
Base Case
$515.79
(+23%)
Market implied 23.9%, PE stable at 17.6
Bear Case
$283.01
(-32%)
Severe decline -20.0%, PE contracts to 15.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 5:40 PM ET
Data refreshes hourly during market hours. Next update: 6:40 PM
Data refreshes hourly during market hours. Next update: 6:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELV showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Amy W Schulman
SELL
26 shares
2026-03-12
Ro Khanna
BUY
2026-02-24
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$105 | 62 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$411 | 59 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 58 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$304 | 61 BUY |
|
CNC
Centene Corp |
BUY
19 analysts |
$62 | 57 HOLD |
Advanced ELV Option Strategies
Professional options setups generated by AI based on today's ELV price and gamma walls.
